1Li YY,Mctiernan CF,Feldman AM.Interplay of matrix metalloproteinase,tissue inhibitors of metalloproteinases and their regulations in cardiac matrix remodeling[J].Cariovasc Res,2000;46(2):214-4.
3Maseri A.Inflammation,atherosclerosis and ischemic eventsexploring the hidden side of the moon[J].N Engl J Med,1997;336(14):1014-6.
4Torzewski J,Torzewski M,Bowyer DE,et al.Creactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J].Arterioscler Thromb Vasc Biol,1998;18(9):1386-92.
6Anderson JL,Carlquist JF,Muhlestein JB,et al.Evaluation of C-reactive protein,an inflammatory marker,and infectious serology as risk factors for coronary artery disease and myocardial infarction[J].J Am Coll Cardiol,1998;32(1):35-41.
7Ridker PM,Rifai N,Pfeffer M,et al.Elevation of tumor necrosis factor (alpha) and increased risk of recurrent coronary events after myocardial infarction [J].Circulation,2000;101:2149-53.
8Ridker PM,Rifai N,Stampfer MJ,et al.Plasma concentration of interleukin6 and the risk of future myocardial infarction among apparently healthy men[J].Circulation,2000;101(15):1767-72.
二级参考文献25
1National Heart,Lung,and Blood Institute Fact Book. Fiscal Year 1995. US Department of Heart and Human Service Monogragh. March,1996:30～52
2Farmer JA,Gotto AM Jr. Dyslipidemia and other risk factors for coronary artery disease. In:Braunwald E,editor. Heart Disease:A Textbook of Cardiovascular Medicine. 5th ed. Philadelphia:Saunders,1997.1126～1160
3Robinson K, Mayer EL,Miller DP,et al. Hyperhomocysteinemia and low pyridoxal phospate:common and independent reversible risk factors for coronary artery disease. Circulation, 1995,92:2825～2830
4Ross R. Ceel biology of atherosclerosis. Annu Rev Physiol, 1995,57:791～804
5Van der Wal AC,Becker AE, Van der Loos CM, et al. Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammation process irrespective of the dominant plaque morphology. Circulation, 1994,89:36～44
6Shah PK,Falk E,Badimon JJ,et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques:potential role of matrix-degrading metalloproteinases and implications for plaque rupture. Circulation, 1995,92:1565～1569
7Maseri A. Inflammation,atherosclerosis,and ischemic events-exploring the hidden side of the moon. N Engl J Med, 1997,336:1014～1016
8Berk BC,Weintraub WS,Alexander RW. Elevation of reactive protein in "active"coronary artery disease. Am J Cardiol, 1990,65:168～172
9de Beer FC,Hind CR,Fox KM, et al. Measurement of serum C-reactive protein concentration in myocardial ischemia and infarction. Br Heart J, 1982,47:239～243
10Pietila K,Marmoinen A,Hermens W, et al. Serum C-reactive protein concentration in myocardial infarct patients with a closed versus an open infarct-related coronary artery after thrombolytic therapy. Eur Heart, 1993,14:915～919
